Correlation Between Lyra Therapeutics and Immunome
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Immunome, you can compare the effects of market volatilities on Lyra Therapeutics and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Immunome.
Diversification Opportunities for Lyra Therapeutics and Immunome
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyra and Immunome is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Immunome go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Immunome
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Immunome. In addition to that, Lyra Therapeutics is 1.19 times more volatile than Immunome. It trades about -0.03 of its total potential returns per unit of risk. Immunome is currently generating about 0.01 per unit of volatility. If you would invest 1,459 in Immunome on September 1, 2024 and sell it today you would lose (104.00) from holding Immunome or give up 7.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Immunome
Performance |
| Timeline |
| Lyra Therapeutics |
| Immunome |
Lyra Therapeutics and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Immunome
The main advantage of trading using opposite Lyra Therapeutics and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |